Recombinant vaccine technology in veterinary medicine.
Recombinant technology is relatively new to veterinary medicine. It combines safety, purity, potency, and efficacy in the vaccine. Its positive features include not exposing the vaccinate to the pathogen, the lack of need for adjuvants, and stability that allows some vaccine to remain viable at ambient temperatures. These recombinants can receive multiple genetic inserts and present an opportunity to have multiple combination vaccines for use in animals. Licensed recombinant vaccines in veterinary medicine include those protecting against Lyme disease, pseudorabies, rabies, canine distemper, Newcastle disease, and a strain of avian influenza.
Van Kampen
K R
KR
Van Kampen Group, Inc., Hoover, Alabama, USA.
D000820:Animal Diseases / Q000517:prevention & control*; D000818:Animals; D014614:Vaccines, Synthetic; D014730:Veterinary Medicine / Q000639:trends
D014614:Vaccines, Synthetic